UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Seeking consistency for the role of urinary macromolecules and glycosaminoglycans in calcium oxalate crystallization processes pertaining to the risk of renal stone formation using a multi-faceted basic science approach

Clinica chimica acta, 2021-10, Vol.521, p.76-84

2021

Volltextzugriff (PDF)

Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds

Clinica chimica acta, 2022-01, Vol.525, p.84-90

2022

Volltextzugriff (PDF)

Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation

The FEBS journal, 2006-07, Vol.273 (13), p.3024-3037

2006

Volltextzugriff (PDF)

Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation

Journal of veterinary internal medicine, 2018-09, Vol.32 (5), p.1517-1529

2018

Volltextzugriff (PDF)

Lack of Pharmacokinetic Interactions Between Cilomilast and Theophylline or Smoking in Healthy Volunteers

Journal of clinical pharmacology, 2004-09, Vol.44 (9), p.1046-1053

2004

Volltextzugriff (PDF)

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and ph, and orocecal and colonic transit: Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers

Clinical therapeutics, 2006-04, Vol.28 (4), p.569-581

2006

Volltextzugriff (PDF)

Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy

Urolithiasis, 2014-06, Vol.42 (3), p.221-225

2014

Volltextzugriff (PDF)

Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease

Journal of endourology, 2014-02, Vol.28 (2), p.229-236

2014

Volltextzugriff (PDF)

Variability in kidney stone incidence between black and white South Africans: AGT Pro11Leu polymorphism is not a factor

Journal of endourology, 2014-05, Vol.28 (5), p.577-581

2014

Volltextzugriff (PDF)

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.950-958

2001

Volltextzugriff (PDF)

Warfarin pharmacodynamics unaffected by cilomilast

The Annals of pharmacotherapy, 2001-12, Vol.35 (12), p.1535-1539

2001

Volltextzugriff (PDF)

Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former

Urolithiasis, 2015-02, Vol.43 (1), p.21-27

2015

Volltextzugriff (PDF)

Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms

Urolithiasis, 2012-04, Vol.40 (2), p.113-120

2012

Volltextzugriff (PDF)

Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains

Diagnostic microbiology and infectious disease, 2008-08, Vol.61 (4), p.387-395

2008

Volltextzugriff (PDF)

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth

Urolithiasis, 2007-12, Vol.35 (6), p.277-285

2007

Volltextzugriff (PDF)

Synergism between Urinary Prothrombin Fragment 1 and Urine: A Comparison of Inhibitory Activities in Stone-Prone and Stone-Free Population Groups

Clinical chemistry and laboratory medicine, 2002-09, Vol.40 (9), p.930-936

2002

Volltextzugriff (PDF)

Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects

Urolithiasis, 2005-08, Vol.33 (4), p.273-284

2005

Volltextzugriff (PDF)

Meta-analysis of QTc interval - pooling data from heterogeneous trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2002-06, Vol.1 (1), p.17-23

2002

Volltextzugriff (PDF)

Bioavailability of the Oral Selective Phosphodiesterase 4 Inhibitor Cilomilast

Pharmacotherapy, 2001-06, Vol.21 (6), p.653-660

2001

Volltextzugriff (PDF)

A NOVEL BAYESIAN DECISION PROCEDURE FOR EARLY-PHASE DOSE-FINDING STUDIES

Journal of biopharmaceutical statistics, 1999-11, Vol.9 (4), p.583-597

1999

Volltextzugriff (PDF)

Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers

Biostatistics (Oxford, England), 2001-03, Vol.2 (1), p.47-61

2001

Volltextzugriff (PDF)

Fourth Amendment. Of Warrants, Electronic Surveillance, Expectations of Privacy, and Tainted Fruits

The journal of criminal law & criminology, 1984-10, Vol.75 (3), p.630-652

Webber, Dawn

1984

Volltextzugriff (PDF)

Joint Employer, Single Employer, and Alter Ego

The Labor lawyer, 1987-10, Vol.3 (4), p.873-887

1987

Volltextzugriff (PDF)

Translating chemometric analysis into physiological insights from in vivo confocal Raman spectroscopy of the human stratum corneum

Biochimica et biophysica acta. Biomembranes, 2019-02, Vol.1861 (2), p.403-409

2019

Volltextzugriff (PDF)

Why Did the “Missing Middle” Miss the Train? An Actors-In-Systems Exploration of Barriers to Intensified Family Housing in Waterloo Region, Canada

Land (Basel), 2023-02, Vol.12 (2), p.434

2023

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Humans
(18)
Male
(12)
Adult
(9)
Adolescent
(7)
Urology & Nephrology
(7)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Middle Aged
(6)
Area Under Curve
(5)
Crystallization
(5)
Cyclohexanecarboxylic Acids
(5)
Female
(5)
Kidney Stones
(5)
Pharmacology & Pharmacy
(5)
African Continental Ancestry Group
(4)
Bronchodilator Agents - Adverse Effects
(4)
Calcium Oxalate - Metabolism
(4)
Calcium Oxalate - Urine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Seeking consistency for the role of urinary macromolecules and glycosaminoglycans in calcium oxalate crystallization processes pertaining to the risk of renal stone formation using a multi-faceted basic science approach

Composition and inhibitory properties of endogenous urinary GAGS are different in subjects from two race groups with different occurrence rates of kidney stones: Pilot studies provide unique evidence in support of an inhibitory role for this group of compounds

Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation

Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation

Lack of Pharmacokinetic Interactions Between Cilomilast and Theophylline or Smoking in Healthy Volunteers

Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and ph, and orocecal and colonic transit: Two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers

Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy

Malic acid supplementation increases urinary citrate excretion and urinary pH: implications for the potential treatment of calcium oxalate stone disease

Variability in kidney stone incidence between black and white South Africans: AGT Pro11Leu polymorphism is not a factor

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

Warfarin pharmacodynamics unaffected by cilomilast

Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former

Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms

Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth

Synergism between Urinary Prothrombin Fragment 1 and Urine: A Comparison of Inhibitory Activities in Stone-Prone and Stone-Free Population Groups

Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects

Meta-analysis of QTc interval - pooling data from heterogeneous trials

Bioavailability of the Oral Selective Phosphodiesterase 4 Inhibitor Cilomilast

A NOVEL BAYESIAN DECISION PROCEDURE FOR EARLY-PHASE DOSE-FINDING STUDIES

Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers

Fourth Amendment. Of Warrants, Electronic Surveillance, Expectations of Privacy, and Tainted Fruits

Joint Employer, Single Employer, and Alter Ego

Translating chemometric analysis into physiological insights from in vivo confocal Raman spectroscopy of the human stratum corneum

Why Did the “Missing Middle” Miss the Train? An Actors-In-Systems Exploration of Barriers to Intensified Family Housing in Waterloo Region, Canada

Suchergebnisse filtern